Publications in collaboration with researchers from Vanderbilt University (35)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization Analyses

    Circulation, Vol. 146, Núm. 20, pp. 1507-1517

  2. Performance of the American Heart Association/American College of Cardiology/Heart Rhythm Society versus European Society of Cardiology guideline criteria for hospital admission of patients with syncope

    Heart Rhythm, Vol. 19, Núm. 10, pp. 1712-1722

  3. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology

    Clinical Microbiology and Infection, Vol. 28, Núm. 4, pp. 580-587

2021

  1. Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2–negative advanced breast cancer: final overall survival results from SOLAR-1

    Annals of Oncology, Vol. 32, Núm. 2, pp. 208-217

  2. Biomarkers for Traumatic Brain Injury: Data Standards and Statistical Considerations

    Journal of Neurotrauma, Vol. 38, Núm. 18, pp. 2514-2529

  3. Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight

    eLife, Vol. 10

  4. Molecular design of the γδT cell receptor ectodomain encodes biologically fit ligand recognition in the absence of mechanosensing

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 118, Núm. 26

  5. Nomenclature in nephrology: preserving ‘renal’ and ‘nephro' in the glossary of kidney health and disease

    Journal of Nephrology, Vol. 34, Núm. 3, pp. 639-648

  6. Quantifying duration of proteinuria remission and association with clinical outcome in IgA nephropathy

    Journal of the American Society of Nephrology, Vol. 32, Núm. 2

  7. Tractography dissection variability: What happens when 42 groups dissect 14 white matter bundles on the same dataset?

    NeuroImage, Vol. 243

2020

  1. Time course and management of key adverse events during the randomized phase III SOLAR-1 study of PI3K inhibitor alpelisib plus fulvestrant in patients with HR-positive advanced breast cancer

    Annals of Oncology, Vol. 31, Núm. 8, pp. 1001-1010

2019

  1. Alpelisib for PIK3CA-mutated, hormone receptor-positive advanced breast cancer

    New England Journal of Medicine, Vol. 380, Núm. 20, pp. 1929-1940

  2. Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials

    The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 2, pp. 128-139

  3. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

    Nature Communications, Vol. 10, Núm. 1

  4. Rising rural body-mass index is the main driver of the global obesity epidemic in adults

    Nature

  5. Risk factors for pleural effusion recurrence in patients with malignancy

    Respirology, Vol. 24, Núm. 1, pp. 76-82

2018

  1. The T Cell Antigen Receptor α Transmembrane Domain Coordinates Triggering through Regulation of Bilayer Immersion and CD3 Subunit Associations

    Immunity, Vol. 49, Núm. 5, pp. 829-841.e6

2017

  1. Disposition of emergency department patients diagnosed with acute heart failure: An international emergency medicine perspective

    European Journal of Emergency Medicine, Vol. 24, Núm. 1, pp. 2-12

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy